Your browser doesn't support javascript.
loading
The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy.
Shu, Chun-Lu; Liu, Yu-Ling.
Affiliation
  • Shu CL; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People's Republic of China.
  • Liu YL; Department of Medical Laboratory Science, Fenyang College of Shanxi Medical University, Feiyang, Shanxi, 032200, People's Republic of China.
Cancer Manag Res ; 14: 3485-3492, 2022.
Article in En | MEDLINE | ID: mdl-36561983
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Manag Res Year: 2022 Document type: Article Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancer Manag Res Year: 2022 Document type: Article Country of publication: New Zealand